Home Finance

FINANCE

September 09, 2025

Qilu Pharmaceutical invests heavily in an innovative microsphere product

Qilu Pharmaceutical and InnoBM Pharmaceuticals have reached an agreement to jointly advance the development of BM601, a metallic embolization microsphere product for TACE treatment of liver cancer. Under the terms of the agreement, Biomay Biotech will receive milestone payments totaling over RMB 200 million, along with additional sales royalties and overseas revenue sharing.

September 10, 2025

"First Investment" completed | Xiamen cardiovascular industry fund strategically invests in TRULIVE to accelerate the construction of an industrial synergistic innovation ecosystem

September 10, 2025

Tripartite cooperation reached in Shanghai, Thousand Oaks Biopharmaceuticals and others announce advancement of international collaboration in biotech field

September 09, 2025

Kexing Biopharm introduces Humanwell PuraCap's Nintedanib Ethanesulfonate to kickstart its global journey in respiratory field

September 09, 2025

[First release] Shanghai RobotGym completes tens of millions of angel+ round financing to advance the implementation of smart elderly care robots

September 08, 2025

Health160 Passes HKEX Hearing, Set to Go Public

September 08, 2025

$1.5 billion: vitamin C giant IVC Nutrition Corporation up for sale

September 08, 2025

Escugen and Hua Huian kin (Beijing) Biotechnology Co., Ltd. join hands to reach a global strategic cooperation on next-generation targeted ADC drugs

September 08, 2025

Yijieliko (Shanghai) Biotechnology Co., Ltd. Announces Completion of $60 Million Series B Financing to Accelerate Clinical Development of Epigenetic Drugs

September 07, 2025

Hengrui Signs Licensing Agreement Worth Over $1 Billion

September 06, 2025

Johnson & Johnson Announces a Major Collaboration

September 05, 2025

RMB 7.8 billion deal overseas! Innovative drug leader, Hengrui Pharmaceuticals, adopts NewCo model again

September 05, 2025

MacroLux Medical and Olympus reach distribution partnership in the global disposable urology products field

September 05, 2025

[First Release]Beijing Shuimu Zhonghui Science and Technology Development Co., Ltd. Completes Hundreds of Millions of Yuan in Series B Financing, Accelerating the Construction of a Full-Process Service Platform for Medical Devices

September 05, 2025

[First Release]Shanghai Baiyi Medical Technology Co., Ltd. Completes Tens of Millions of Yuan in Series A Financing, Fills the Gap in Full-course Thyroid Disease Management, and Embarks on International Journey

September 05, 2025

[First Release] Rui Long Surgical Secures Over $100 Million in Financing, Partners with Johnson & Johnson for Strategic Collaboration

September 04, 2025

100 Million Yuan Upfront Payment! Domestic Bispecific ADC Goes Global

September 04, 2025

RMB 237 million: Artificial Intelligence Drug Discovery Platform of ShanghaiTech University Achieves Technology Transfer

September 04, 2025

$5.4 Billion: Novartis bets on a Chinese siRNA drug

September 03, 2025

A Domestic Dual-Antibody ADC Successfully Completes Outward BD

September 03, 2025

Berry Genomics partners with Tencent Cloud to embark on a new journey of AI-driven life and health